The popularity of Sildenafil initially fueled a boom for major pharmaceutical companies, but recent shifts present a uncertain outlook for those considering a stake. Off-patent competitors are eroding profits, and https://zubairmstu583649.blogscribble.com/41429101/viagra-and-pharma-a-risky-play